Helicobacter pylori and non-steroidal anti-inflammatory drugs: does infection affect the outcome of NSAID therapy?

1. H. pylori gastritis appears to increase the likelihood of developing dyspeptic symptoms on NSAID therapy. 2. There is preliminary evidence that the histologic severity of H. pylori gastritis may be adversely affected by NSAID therapy, with a consequent increase in the risk of developing a peptic...

Descripción completa

Detalles Bibliográficos
Autor principal: McCarthy, D. M.
Formato: Texto
Lenguaje:English
Publicado: Yale Journal of Biology and Medicine 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2578884/
https://www.ncbi.nlm.nih.gov/pubmed/10378355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2578884/
https://www.ncbi.nlm.nih.gov/pubmed/10378355

Ejemplares similares